View ValuationElixirr International 将来の成長Future 基準チェック /46Elixirr International利益と収益がそれぞれ年間18.3%と11.2%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に21.8% 13.5%なると予測されています。主要情報18.3%収益成長率13.52%EPS成長率Professional Services 収益成長11.4%収益成長率11.2%将来の株主資本利益率21.80%アナリストカバレッジLow最終更新日29 Apr 2026今後の成長に関する最新情報お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.お知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.お知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.お知らせ • Sep 20Elixirr International plc Provides Revenue Guidance for the Full Year 2022Elixirr International plc announced revenue guidance for the full year 2022. For the period, group expects revenue to be in the range of £70 million to £75 million.お知らせ • Feb 01+ 1 more updateElixirr International plc Provides Group Earnings Guidance for the Year Ended December 31, 2021Elixirr International plc provided group earnings guidance for the year ended December 31, 2021. For the period the group expects to record revenue of approximately £50.5 million.すべての更新を表示Recent updatesお知らせ • Apr 20Elixirr International plc Recommends Final Dividend for Fiscal Year 2025, Payable on August 2026Elixirr International plc announced the Board recommend a final dividend for Fiscal Year 25 of 15.0 pence per Ordinary Share, payable in August 2026 making a total dividend of 22.6 pence for the Fiscal Year 25 financial year, a 27% increase on the Fiscal Year 24 dividend. The final dividend will be recommended to shareholders at the AGM in June 2026. The Fiscal Year 25 final dividend will have a total cash cost of £7.5 million.お知らせ • Feb 03Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million.Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million on January 30, 2026. The maximum consideration payable under the terms of the Acquisition is DKK154.8 million, consisting of Initial cash consideration of DKK78.8 million, subject to customary working capital adjustments and holdbacks at completion, which has been settled from the Group's operating cashflow and revolving credit facility, DKK28.8 million to be settled through the issuance of 415,213 new ordinary shares, deferred consideration of up to DKK47.3 million (GBP£5.5 million), payable in cash or Ordinary Shares at the Company's discretion, which is contingent on Kvadrant achieving EBITDA margin and revenue targets in periods up to December 31, 2028. Elixirr International plc (LSE:ELIX) completed the acquisition of Kvadrant Consulting A/S on January 30, 2026.お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026お知らせ • Sep 22+ 1 more updateElixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory.Elixirr International plc (LSE:ELIX) acquired TRC Advisory for approximately $130 million on September 19, 2025. A cash consideration of $41 million and common equity of Elixirr International plc having a value of $16 million will be issued for common equity of TRC Advisory. Elixirr International plc will pay an earnout/contingent payment of $24 million cash and of $8 million common equity. A further deferred performance-based payment of up to $36 million, payable over three years (2026, 2027 and 2028) in three instalments, either in cash or through the allotment and issue of further new Ordinary Shares. As part of consideration, $125 million is paid towards common equity of TRC Advisory. Elixirr has agreed the option of a US$20.25 million Loan and an increase in its Facility with NatWest from £45 million to £65 million. For the period ending December 31, 2024, TRC Advisory reported total revenue of $28.8 million and EBITDA of $13.5 million. Tim Romberger (Founder & Managing Director), Cyrus Patel (Managing Director), Mark Skoskiewicz (Director), Garan Geist (Director), Mason Kissell (Managing Director) and Hemal Vyas (Director) will, following Completion, become Partners in Elixirr. Employee retention has been considered as part of the consideration structure for the Acquisition in order to mitigate this risk. Elixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory on September 19, 2025.お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025お知らせ • May 30Elixirr International plc, Annual General Meeting, Jun 24, 2025Elixirr International plc, Annual General Meeting, Jun 24, 2025. Location: lainston house, woodman lane, sparsholt, winchester, so21 2lt, United Kingdomお知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.お知らせ • Dec 20Elixirr International plc Declares Interim Dividend for the Year Ending 31 December 2024, Payable on January 24, 2025The Board of Elixirr International plc confirmed the amount and timing of its interim dividend for the year ending 31 December 2024. In accordance with the Company's dividend policy announced on 8 January 2024, the Company will continue to declare two dividends per year, with an interim dividend paid after the end of the year and a final dividend payable in August. The Company is declaring an interim dividend of 6.3 pence per Ordinary Share. The Dividend will be payable to Shareholders on the register as at 24 January 2025 and has an associated ex-dividend date of 23 January 2025. The Dividend of approximately £3.0 million in total will be paid to Shareholders on 17 February 2025 and funded from the Company's operating cash flow.お知らせ • Dec 11Elixirr International plc Announces Changes to Chief Financial Officer, with Effect from 1 January 2025Elixirr International plc announced that Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures.お知らせ • Dec 10Elixirr International plc Announces Management ChangesElixirr International plc announced the following changes to its Board of Directors. Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Stephen Newton will continue as Chief Executive Officer. The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €9.10, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Professional Services industry in Europe. Total returns to shareholders of 18% over the past three years.Recent Insider Transactions • Oct 28Founder recently sold €12m worth of stockOn the 25th of October, Stephen Newton sold around 2m shares on-market at roughly €7.80 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Stephen's only on-market trade for the last 12 months.お知らせ • Oct 26+ 1 more updateElixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million.Elixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,153 Price\Range: £6.5 Transaction Features: Subsequent Direct ListingReported Earnings • Sep 25First half 2024 earnings released: EPS: UK£0.19 (vs UK£0.17 in 1H 2023)First half 2024 results: EPS: UK£0.19 (up from UK£0.17 in 1H 2023). Revenue: UK£53.0m (up 28% from 1H 2023). Net income: UK£8.84m (up 15% from 1H 2023). Profit margin: 17% (down from 19% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.Upcoming Dividend • Jul 18Upcoming dividend of UK£0.095 per shareEligible shareholders must have bought the stock before 25 July 2024. Payment date: 20 August 2024. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (2.3%).New Risk • Jul 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (3.5% increase in shares outstanding). Significant insider selling over the past 3 months (€4.8m sold).Recent Insider Transactions • Jul 10Independent Non-Executive Chairman recently sold €1.2m worth of stockOn the 8th of July, Gavin Patterson sold around 177k shares on-market at roughly €6.69 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Gavin's only on-market trade for the last 12 months.Declared Dividend • Jun 03Final dividend of UK£0.095 announcedShareholders will receive a dividend of UK£0.095. Ex-date: 25th July 2024 Payment date: 20th August 2024 Dividend yield will be 2.3%, which is higher than the industry average of 1.8%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 105% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jun 02Elixirr International plc, Annual General Meeting, Jun 25, 2024Elixirr International plc, Annual General Meeting, Jun 25, 2024. Location: lainston house, woodman lane, sparsholt, winchester so21 2lt, United Kingdomお知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.Reported Earnings • Apr 22Full year 2023 earnings released: EPS: UK£0.38 (vs UK£0.28 in FY 2022)Full year 2023 results: EPS: UK£0.38 (up from UK£0.28 in FY 2022). Revenue: UK£85.9m (up 22% from FY 2022). Net income: UK£17.2m (up 34% from FY 2022). Profit margin: 20% (up from 18% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024New Risk • Feb 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding).Upcoming Dividend • Jan 11Upcoming dividend of UK£0.053 per share at 1.8% yieldEligible shareholders must have bought the stock before 18 January 2024. Payment date: 15 February 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.9%). Lower than average of industry peers (2.4%).お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €6.95, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Professional Services industry in Europe. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €11.69 per share.お知らせ • Dec 12Elixirr International plc (AIM:ELIX) acquired Insigniam $18.5 million.Elixirr International plc (AIM:ELIX) acquired Insigniam for $18.5 million on December 11, 2023. As part of the acquisition, Elixirr welcomes four new partners into the team: Insigniam Founding Partners Shideh Bina and Nathan Rosenberg, as well as Katerin Le Folcalvez and Jennifer Zimmer. Elixirr International plc (AIM:ELIX) completed the acquisition of Insigniam on December 11, 2023.New Risk • Nov 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding).New Risk • Sep 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (2.3% increase in shares outstanding).Reported Earnings • Sep 19First half 2023 earnings released: EPS: UK£0.17 (vs UK£0.14 in 1H 2022)First half 2023 results: EPS: UK£0.17 (up from UK£0.14 in 1H 2022). Revenue: UK£41.1m (up 23% from 1H 2022). Net income: UK£7.67m (up 15% from 1H 2022). Profit margin: 19% (down from 20% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Professional Services industry in Europe.お知らせ • Sep 19+ 1 more updateElixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million.Elixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million on September 18, 2023. The consideration consists of Potential earn-out payments of up to $1.0 million in cash and consideration of $3.4 million to be settled through the issue in September 2023 of 505,196 Elixirr International plc Ordinary shares. The Ordinary Shares purchased pursuant to the Acquisition will be subject to restrictions on sale for a total period of up to 4 years. The sellers have also agreed 3-year restrictive covenants. Responsum was co-founded by Steve Steinberg (CEO) and Adam Hofmann (Chief Marketing Officer). Steve will continue to lead the business following the Acquisition. Elixirr International plc (AIM:ELIX) completed the acquisition of Responsum, Inc. on September 18, 2023.Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Independent Non-Executive Director Simon Retter was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.85, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Professional Services industry in Europe. Total returns to shareholders of 193% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.77 per share.Upcoming Dividend • Jul 13Upcoming dividend of UK£0.11 per share at 2.3% yieldEligible shareholders must have bought the stock before 20 July 2023. Payment date: 18 August 2023. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (2.8%).お知らせ • May 19+ 1 more updateElixirr International plc, Annual General Meeting, Jun 13, 2023Elixirr International plc, Annual General Meeting, Jun 13, 2023, at 08:00 Coordinated Universal Time. Location: 00 Cheapside, EC2V 6DT London United KingdomReported Earnings • Apr 08Full year 2022 earnings released: EPS: UK£0.28 (vs UK£0.22 in FY 2021)Full year 2022 results: EPS: UK£0.28 (up from UK£0.22 in FY 2021). Revenue: UK£70.7m (up 40% from FY 2021). Net income: UK£12.9m (up 27% from FY 2021). Profit margin: 18% (down from 20% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Professional Services industry in Europe.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €4.50, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Professional Services industry in Europe. Total loss to shareholders of 37% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €7.60 per share.Recent Insider Transactions • Nov 19Independent Non-Executive Director recently bought €75k worth of stockOn the 10th of November, Simon Retter bought around 13k shares on-market at roughly €5.91 per share. This transaction amounted to 3.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €7.2m more in shares than they bought in the last 12 months.Reported Earnings • Sep 21First half 2022 earnings released: EPS: UK£0.14 (vs UK£0.11 in 1H 2021)First half 2022 results: EPS: UK£0.14 (up from UK£0.11 in 1H 2021). Revenue: UK£33.4m (up 39% from 1H 2021). Net income: UK£6.67m (up 31% from 1H 2021). Profit margin: 20% (down from 21% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Professional Services industry in Europe.お知らせ • Sep 20Elixirr International plc Provides Revenue Guidance for the Full Year 2022Elixirr International plc announced revenue guidance for the full year 2022. For the period, group expects revenue to be in the range of £70 million to £75 million.お知らせ • Sep 13Elixirr International plc to Report Q2, 2022 Results on Sep 20, 2022Elixirr International plc announced that they will report Q2, 2022 results on Sep 20, 2022Valuation Update With 7 Day Price Move • Aug 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to €7.85, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Professional Services industry in Europe. Total returns to shareholders of 25% over the past year.お知らせ • Aug 02Elixirr International plc (AIM:ELIX) acquired Kit Consulting S.R.L.Elixirr International plc (AIM:ELIX) acquired Kit Consulting S.R.L. on August 1, 2022. Elixirr International plc (AIM:ELIX) completed the acquisition of Kit Consulting S.R.L. on August 1, 2022.Upcoming Dividend • Jul 07Upcoming dividend of UK£0.041 per shareEligible shareholders must have bought the stock before 14 July 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (2.6%).お知らせ • May 20Elixirr International plc, Annual General Meeting, Jun 13, 2022Elixirr International plc, Annual General Meeting, Jun 13, 2022, at 08:30 Coordinated Universal Time. Location: 100 Cheapside, EC2V 6DT London United Kingdomお知らせ • May 19Elixirr International plc Proposes Dividend, Payable on 12 August 2022Elixirr International plc announced that in addition, further to the announcement on 4 April 2022, the Company confirms the dates relevant to the payment of the dividend of 4.1 pence per share are as follows: Ex-dividend date is 14 July 2022. Record date is 15 July 2022. Payment date is 12 August 2022.Recent Insider Transactions • Apr 10Founder recently sold €6.0m worth of stockOn the 8th of April, Stephen Newton sold around 654k shares on-market at roughly €9.16 per share. This was the largest sale by an insider in the last 3 months. This was Stephen's only on-market trade for the last 12 months.Reported Earnings • Apr 05Full year 2021 earnings released: EPS: UK£0.22 (vs UK£0.12 in FY 2020)Full year 2021 results: EPS: UK£0.22 (up from UK£0.12 in FY 2020). Revenue: UK£50.6m (up 67% from FY 2020). Net income: UK£10.1m (up 112% from FY 2020). Profit margin: 20% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 43%, compared to a 9.4% growth forecast for the industry in Germany.お知らせ • Apr 04Elixirr International plc Proposes Final Ordinary Share Dividend for the Fiscal Year 2021The Directors of Elixirr International plc are proposing a final Ordinary share dividend in respect of Fiscal Year 2021 of 4.1 pence per Ordinary share, representing an 86% increase in dividend per share compared with Fiscal Year 2020.Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to €8.30, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 18x in the Professional Services industry in Europe. Total returns to shareholders of 85% over the past year.お知らせ • Feb 01+ 1 more updateElixirr International plc Provides Group Earnings Guidance for the Year Ended December 31, 2021Elixirr International plc provided group earnings guidance for the year ended December 31, 2021. For the period the group expects to record revenue of approximately £50.5 million.Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Non-Executive Chairman Gavin Patterson is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Recent Insider Transactions • Dec 02Insider recently bought €59k worth of stockOn the 29th of November, Nicholas Willott bought around 8k shares on-market at roughly €7.67 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €81k more in shares than they have sold in the last 12 months.お知らせ • Jun 17Elixirr International plc Revises Earnings Guidance for the Year Ending 31 December 2021Elixirr International plc revised earnings guidance for the year ending 31 December 2021. The Board now expects revenue for the year ending 31 December 2021 to be towards the upper end of the range previously indicated to the market, i.e. revenue in the upper range of £44-47 million.お知らせ • May 26Elixirr International plc Proposes Final Dividend for the Year Ended 31 December 2020, Payable on 13 August 2021In addition, further to the announcement on 12 April 2021 of its final results for the year ended 31 December 2020, Elixirr International plc is proposing a final dividend of 2.2 pence per ordinary share (the "Dividend") at its Annual General Meeting ("AGM") to be held on 16 June 2021. If approved by the passing of the relevant shareholder resolution at the AGM, it is intended that the Dividend will be paid on 13 August 2021. Ex-dividend date is 15 July 2021. Record date is 16 July 2021.Is New 90 Day High Low • Mar 11New 90-day high: €4.39The company is up 54% from its price of €2.84 on 10 December 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 10.0% over the same period.Is New 90 Day High Low • Feb 09New 90-day high: €3.83The company is up 40% from its price of €2.74 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 1.0% over the same period.お知らせ • Feb 08Elixirr International plc to Report Fiscal Year 2020 Results on Apr 12, 2021Elixirr International plc announced that they will report fiscal year 2020 results on Apr 12, 2021Is New 90 Day High Low • Jan 20New 90-day high: €3.80The company is up 39% from its price of €2.74 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 6.0% over the same period.Is New 90 Day High Low • Dec 30New 90-day high: €3.61The company is up 46% from its price of €2.48 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 6.0% over the same period.Is New 90 Day High Low • Dec 15New 90-day high: €2.95The company is up 22% from its price of €2.41 on 16 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is flat over the same period.Is New 90 Day High Low • Nov 25New 90-day high: €2.77The company is up 14% from its price of €2.42 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 21New 90-day high: €2.75The company is up 33% from its price of €2.06 on 22 July 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 3.0% over the same period.業績と収益の成長予測DB:54K - アナリストの将来予測と過去の財務データ ( )GBP Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2028215374860412/31/2027201334557412/31/2026187303950412/31/2025150203333N/A9/30/2025140193232N/A6/30/2025130193031N/A3/31/2025121173030N/A12/31/2024111162929N/A9/30/2024104172525N/A6/30/202497182021N/A3/31/202492181819N/A12/31/202386171717N/A9/30/202383161818N/A6/30/202380141919N/A3/31/202376131717N/A12/31/202272131516N/A9/30/202266121414N/A6/30/202260121212N/A3/31/202255111313N/A12/31/202151101414N/A9/30/20214691212N/A6/30/202141899N/A3/31/20213661111N/A12/31/20203051212N/A12/31/201926233N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 54Kの予測収益成長率 (年間18.3% ) は 貯蓄率 ( 1.9% ) を上回っています。収益対市場: 54Kの収益 ( 18.3% ) はGerman市場 ( 17.2% ) よりも速いペースで成長すると予測されています。高成長収益: 54Kの収益は増加すると予測されていますが、大幅には増加しません。収益対市場: 54Kの収益 ( 11.2% ) German市場 ( 6.8% ) よりも速いペースで成長すると予測されています。高い収益成長: 54Kの収益 ( 11.2% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 54Kの 自己資本利益率 は、3年後には高くなると予測されています ( 21.8 %)成長企業の発掘7D1Y7D1Y7D1YCommercial-services 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/25 07:29終値2026/05/25 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Elixirr International plc 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関James FletcherBerenbergGuy HewettCavendishMichael DonnellyInvestec Bank plc (UK)3 その他のアナリストを表示
お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.
お知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.
お知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.
お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.
お知らせ • Sep 20Elixirr International plc Provides Revenue Guidance for the Full Year 2022Elixirr International plc announced revenue guidance for the full year 2022. For the period, group expects revenue to be in the range of £70 million to £75 million.
お知らせ • Feb 01+ 1 more updateElixirr International plc Provides Group Earnings Guidance for the Year Ended December 31, 2021Elixirr International plc provided group earnings guidance for the year ended December 31, 2021. For the period the group expects to record revenue of approximately £50.5 million.
お知らせ • Apr 20Elixirr International plc Recommends Final Dividend for Fiscal Year 2025, Payable on August 2026Elixirr International plc announced the Board recommend a final dividend for Fiscal Year 25 of 15.0 pence per Ordinary Share, payable in August 2026 making a total dividend of 22.6 pence for the Fiscal Year 25 financial year, a 27% increase on the Fiscal Year 24 dividend. The final dividend will be recommended to shareholders at the AGM in June 2026. The Fiscal Year 25 final dividend will have a total cash cost of £7.5 million.
お知らせ • Feb 03Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million.Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million on January 30, 2026. The maximum consideration payable under the terms of the Acquisition is DKK154.8 million, consisting of Initial cash consideration of DKK78.8 million, subject to customary working capital adjustments and holdbacks at completion, which has been settled from the Group's operating cashflow and revolving credit facility, DKK28.8 million to be settled through the issuance of 415,213 new ordinary shares, deferred consideration of up to DKK47.3 million (GBP£5.5 million), payable in cash or Ordinary Shares at the Company's discretion, which is contingent on Kvadrant achieving EBITDA margin and revenue targets in periods up to December 31, 2028. Elixirr International plc (LSE:ELIX) completed the acquisition of Kvadrant Consulting A/S on January 30, 2026.
お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026
お知らせ • Sep 22+ 1 more updateElixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory.Elixirr International plc (LSE:ELIX) acquired TRC Advisory for approximately $130 million on September 19, 2025. A cash consideration of $41 million and common equity of Elixirr International plc having a value of $16 million will be issued for common equity of TRC Advisory. Elixirr International plc will pay an earnout/contingent payment of $24 million cash and of $8 million common equity. A further deferred performance-based payment of up to $36 million, payable over three years (2026, 2027 and 2028) in three instalments, either in cash or through the allotment and issue of further new Ordinary Shares. As part of consideration, $125 million is paid towards common equity of TRC Advisory. Elixirr has agreed the option of a US$20.25 million Loan and an increase in its Facility with NatWest from £45 million to £65 million. For the period ending December 31, 2024, TRC Advisory reported total revenue of $28.8 million and EBITDA of $13.5 million. Tim Romberger (Founder & Managing Director), Cyrus Patel (Managing Director), Mark Skoskiewicz (Director), Garan Geist (Director), Mason Kissell (Managing Director) and Hemal Vyas (Director) will, following Completion, become Partners in Elixirr. Employee retention has been considered as part of the consideration structure for the Acquisition in order to mitigate this risk. Elixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory on September 19, 2025.
お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025
お知らせ • May 30Elixirr International plc, Annual General Meeting, Jun 24, 2025Elixirr International plc, Annual General Meeting, Jun 24, 2025. Location: lainston house, woodman lane, sparsholt, winchester, so21 2lt, United Kingdom
お知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025
お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.
お知らせ • Dec 20Elixirr International plc Declares Interim Dividend for the Year Ending 31 December 2024, Payable on January 24, 2025The Board of Elixirr International plc confirmed the amount and timing of its interim dividend for the year ending 31 December 2024. In accordance with the Company's dividend policy announced on 8 January 2024, the Company will continue to declare two dividends per year, with an interim dividend paid after the end of the year and a final dividend payable in August. The Company is declaring an interim dividend of 6.3 pence per Ordinary Share. The Dividend will be payable to Shareholders on the register as at 24 January 2025 and has an associated ex-dividend date of 23 January 2025. The Dividend of approximately £3.0 million in total will be paid to Shareholders on 17 February 2025 and funded from the Company's operating cash flow.
お知らせ • Dec 11Elixirr International plc Announces Changes to Chief Financial Officer, with Effect from 1 January 2025Elixirr International plc announced that Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures.
お知らせ • Dec 10Elixirr International plc Announces Management ChangesElixirr International plc announced the following changes to its Board of Directors. Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Stephen Newton will continue as Chief Executive Officer. The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.
Valuation Update With 7 Day Price Move • Nov 08Investor sentiment improves as stock rises 20%After last week's 20% share price gain to €9.10, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Professional Services industry in Europe. Total returns to shareholders of 18% over the past three years.
Recent Insider Transactions • Oct 28Founder recently sold €12m worth of stockOn the 25th of October, Stephen Newton sold around 2m shares on-market at roughly €7.80 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Stephen's only on-market trade for the last 12 months.
お知らせ • Oct 26+ 1 more updateElixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million.Elixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,153 Price\Range: £6.5 Transaction Features: Subsequent Direct Listing
Reported Earnings • Sep 25First half 2024 earnings released: EPS: UK£0.19 (vs UK£0.17 in 1H 2023)First half 2024 results: EPS: UK£0.19 (up from UK£0.17 in 1H 2023). Revenue: UK£53.0m (up 28% from 1H 2023). Net income: UK£8.84m (up 15% from 1H 2023). Profit margin: 17% (down from 19% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.
Upcoming Dividend • Jul 18Upcoming dividend of UK£0.095 per shareEligible shareholders must have bought the stock before 25 July 2024. Payment date: 20 August 2024. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 3.5%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (2.3%).
New Risk • Jul 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.5% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (3.5% increase in shares outstanding). Significant insider selling over the past 3 months (€4.8m sold).
Recent Insider Transactions • Jul 10Independent Non-Executive Chairman recently sold €1.2m worth of stockOn the 8th of July, Gavin Patterson sold around 177k shares on-market at roughly €6.69 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Gavin's only on-market trade for the last 12 months.
Declared Dividend • Jun 03Final dividend of UK£0.095 announcedShareholders will receive a dividend of UK£0.095. Ex-date: 25th July 2024 Payment date: 20th August 2024 Dividend yield will be 2.3%, which is higher than the industry average of 1.8%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 105% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 16% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 02Elixirr International plc, Annual General Meeting, Jun 25, 2024Elixirr International plc, Annual General Meeting, Jun 25, 2024. Location: lainston house, woodman lane, sparsholt, winchester so21 2lt, United Kingdom
お知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.
Reported Earnings • Apr 22Full year 2023 earnings released: EPS: UK£0.38 (vs UK£0.28 in FY 2022)Full year 2023 results: EPS: UK£0.38 (up from UK£0.28 in FY 2022). Revenue: UK£85.9m (up 22% from FY 2022). Net income: UK£17.2m (up 34% from FY 2022). Profit margin: 20% (up from 18% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Professional Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024
New Risk • Feb 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding).
Upcoming Dividend • Jan 11Upcoming dividend of UK£0.053 per share at 1.8% yieldEligible shareholders must have bought the stock before 18 January 2024. Payment date: 15 February 2024. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.9%). Lower than average of industry peers (2.4%).
お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.
Valuation Update With 7 Day Price Move • Dec 30Investor sentiment improves as stock rises 19%After last week's 19% share price gain to €6.95, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 16x in the Professional Services industry in Europe. Total returns to shareholders of 99% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €11.69 per share.
お知らせ • Dec 12Elixirr International plc (AIM:ELIX) acquired Insigniam $18.5 million.Elixirr International plc (AIM:ELIX) acquired Insigniam for $18.5 million on December 11, 2023. As part of the acquisition, Elixirr welcomes four new partners into the team: Insigniam Founding Partners Shideh Bina and Nathan Rosenberg, as well as Katerin Le Folcalvez and Jennifer Zimmer. Elixirr International plc (AIM:ELIX) completed the acquisition of Insigniam on December 11, 2023.
New Risk • Nov 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding).
New Risk • Sep 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Shareholders have been diluted in the past year (2.3% increase in shares outstanding).
Reported Earnings • Sep 19First half 2023 earnings released: EPS: UK£0.17 (vs UK£0.14 in 1H 2022)First half 2023 results: EPS: UK£0.17 (up from UK£0.14 in 1H 2022). Revenue: UK£41.1m (up 23% from 1H 2022). Net income: UK£7.67m (up 15% from 1H 2022). Profit margin: 19% (down from 20% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Professional Services industry in Europe.
お知らせ • Sep 19+ 1 more updateElixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million.Elixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million on September 18, 2023. The consideration consists of Potential earn-out payments of up to $1.0 million in cash and consideration of $3.4 million to be settled through the issue in September 2023 of 505,196 Elixirr International plc Ordinary shares. The Ordinary Shares purchased pursuant to the Acquisition will be subject to restrictions on sale for a total period of up to 4 years. The sellers have also agreed 3-year restrictive covenants. Responsum was co-founded by Steve Steinberg (CEO) and Adam Hofmann (Chief Marketing Officer). Steve will continue to lead the business following the Acquisition. Elixirr International plc (AIM:ELIX) completed the acquisition of Responsum, Inc. on September 18, 2023.
Board Change • Aug 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. Independent Non-Executive Director Simon Retter was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €5.85, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Professional Services industry in Europe. Total returns to shareholders of 193% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.77 per share.
Upcoming Dividend • Jul 13Upcoming dividend of UK£0.11 per share at 2.3% yieldEligible shareholders must have bought the stock before 20 July 2023. Payment date: 18 August 2023. Payout ratio is a comfortable 39% and this is well supported by cash flows. Trailing yield: 2.3%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (2.8%).
お知らせ • May 19+ 1 more updateElixirr International plc, Annual General Meeting, Jun 13, 2023Elixirr International plc, Annual General Meeting, Jun 13, 2023, at 08:00 Coordinated Universal Time. Location: 00 Cheapside, EC2V 6DT London United Kingdom
Reported Earnings • Apr 08Full year 2022 earnings released: EPS: UK£0.28 (vs UK£0.22 in FY 2021)Full year 2022 results: EPS: UK£0.28 (up from UK£0.22 in FY 2021). Revenue: UK£70.7m (up 40% from FY 2021). Net income: UK£12.9m (up 27% from FY 2021). Profit margin: 18% (down from 20% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Professional Services industry in Europe.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €4.50, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Professional Services industry in Europe. Total loss to shareholders of 37% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €7.60 per share.
Recent Insider Transactions • Nov 19Independent Non-Executive Director recently bought €75k worth of stockOn the 10th of November, Simon Retter bought around 13k shares on-market at roughly €5.91 per share. This transaction amounted to 3.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €7.2m more in shares than they bought in the last 12 months.
Reported Earnings • Sep 21First half 2022 earnings released: EPS: UK£0.14 (vs UK£0.11 in 1H 2021)First half 2022 results: EPS: UK£0.14 (up from UK£0.11 in 1H 2021). Revenue: UK£33.4m (up 39% from 1H 2021). Net income: UK£6.67m (up 31% from 1H 2021). Profit margin: 20% (down from 21% in 1H 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Professional Services industry in Europe.
お知らせ • Sep 20Elixirr International plc Provides Revenue Guidance for the Full Year 2022Elixirr International plc announced revenue guidance for the full year 2022. For the period, group expects revenue to be in the range of £70 million to £75 million.
お知らせ • Sep 13Elixirr International plc to Report Q2, 2022 Results on Sep 20, 2022Elixirr International plc announced that they will report Q2, 2022 results on Sep 20, 2022
Valuation Update With 7 Day Price Move • Aug 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to €7.85, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Professional Services industry in Europe. Total returns to shareholders of 25% over the past year.
お知らせ • Aug 02Elixirr International plc (AIM:ELIX) acquired Kit Consulting S.R.L.Elixirr International plc (AIM:ELIX) acquired Kit Consulting S.R.L. on August 1, 2022. Elixirr International plc (AIM:ELIX) completed the acquisition of Kit Consulting S.R.L. on August 1, 2022.
Upcoming Dividend • Jul 07Upcoming dividend of UK£0.041 per shareEligible shareholders must have bought the stock before 14 July 2022. Payment date: 12 August 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (2.6%).
お知らせ • May 20Elixirr International plc, Annual General Meeting, Jun 13, 2022Elixirr International plc, Annual General Meeting, Jun 13, 2022, at 08:30 Coordinated Universal Time. Location: 100 Cheapside, EC2V 6DT London United Kingdom
お知らせ • May 19Elixirr International plc Proposes Dividend, Payable on 12 August 2022Elixirr International plc announced that in addition, further to the announcement on 4 April 2022, the Company confirms the dates relevant to the payment of the dividend of 4.1 pence per share are as follows: Ex-dividend date is 14 July 2022. Record date is 15 July 2022. Payment date is 12 August 2022.
Recent Insider Transactions • Apr 10Founder recently sold €6.0m worth of stockOn the 8th of April, Stephen Newton sold around 654k shares on-market at roughly €9.16 per share. This was the largest sale by an insider in the last 3 months. This was Stephen's only on-market trade for the last 12 months.
Reported Earnings • Apr 05Full year 2021 earnings released: EPS: UK£0.22 (vs UK£0.12 in FY 2020)Full year 2021 results: EPS: UK£0.22 (up from UK£0.12 in FY 2020). Revenue: UK£50.6m (up 67% from FY 2020). Net income: UK£10.1m (up 112% from FY 2020). Profit margin: 20% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 43%, compared to a 9.4% growth forecast for the industry in Germany.
お知らせ • Apr 04Elixirr International plc Proposes Final Ordinary Share Dividend for the Fiscal Year 2021The Directors of Elixirr International plc are proposing a final Ordinary share dividend in respect of Fiscal Year 2021 of 4.1 pence per Ordinary share, representing an 86% increase in dividend per share compared with Fiscal Year 2020.
Valuation Update With 7 Day Price Move • Mar 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to €8.30, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 18x in the Professional Services industry in Europe. Total returns to shareholders of 85% over the past year.
お知らせ • Feb 01+ 1 more updateElixirr International plc Provides Group Earnings Guidance for the Year Ended December 31, 2021Elixirr International plc provided group earnings guidance for the year ended December 31, 2021. For the period the group expects to record revenue of approximately £50.5 million.
Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. Independent Non-Executive Chairman Gavin Patterson is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Recent Insider Transactions • Dec 02Insider recently bought €59k worth of stockOn the 29th of November, Nicholas Willott bought around 8k shares on-market at roughly €7.67 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €81k more in shares than they have sold in the last 12 months.
お知らせ • Jun 17Elixirr International plc Revises Earnings Guidance for the Year Ending 31 December 2021Elixirr International plc revised earnings guidance for the year ending 31 December 2021. The Board now expects revenue for the year ending 31 December 2021 to be towards the upper end of the range previously indicated to the market, i.e. revenue in the upper range of £44-47 million.
お知らせ • May 26Elixirr International plc Proposes Final Dividend for the Year Ended 31 December 2020, Payable on 13 August 2021In addition, further to the announcement on 12 April 2021 of its final results for the year ended 31 December 2020, Elixirr International plc is proposing a final dividend of 2.2 pence per ordinary share (the "Dividend") at its Annual General Meeting ("AGM") to be held on 16 June 2021. If approved by the passing of the relevant shareholder resolution at the AGM, it is intended that the Dividend will be paid on 13 August 2021. Ex-dividend date is 15 July 2021. Record date is 16 July 2021.
Is New 90 Day High Low • Mar 11New 90-day high: €4.39The company is up 54% from its price of €2.84 on 10 December 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Feb 09New 90-day high: €3.83The company is up 40% from its price of €2.74 on 10 November 2020. The German market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 1.0% over the same period.
お知らせ • Feb 08Elixirr International plc to Report Fiscal Year 2020 Results on Apr 12, 2021Elixirr International plc announced that they will report fiscal year 2020 results on Apr 12, 2021
Is New 90 Day High Low • Jan 20New 90-day high: €3.80The company is up 39% from its price of €2.74 on 22 October 2020. The German market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Dec 30New 90-day high: €3.61The company is up 46% from its price of €2.48 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Dec 15New 90-day high: €2.95The company is up 22% from its price of €2.41 on 16 September 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is flat over the same period.
Is New 90 Day High Low • Nov 25New 90-day high: €2.77The company is up 14% from its price of €2.42 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 21New 90-day high: €2.75The company is up 33% from its price of €2.06 on 22 July 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is up 3.0% over the same period.